Stocks
Single names, sectors, valuations and the trades behind the tape, explained in plain language.
Uber's $14.8B Delivery Hero Deal Lifts Shares, Consumer Stocks Rise Broadly
Uber announced a $14.8 billion merger agreement with Delivery Hero on Thursday, sending its shares up 1.2%. Consumer stocks broadly climbed,
Csquare IPO Priced Below Range as Investors Demand Cushion on AI Infrastructure Deals
Csquare's IPO priced at $21, below the $23-27 range, and slipped 3% on debut. The tepid reception signals that public investors are demandin
Verizon Sells 274 Stores, Cuts 500 Jobs as It Shifts to Franchise Model
Verizon is selling 274 company-owned stores and cutting about 500 corporate jobs, shifting more of its retail footprint to franchise partner
Toyota's $10.4 Billion Hilux Upgrade in South Africa Nears Completion, Eyes EU Market
Toyota South Africa is 77% done with its 10.4 billion rand Hilux upgrade, with pilot production already running in Durban. The overhaul, set
Pentair Cuts Outlook as Pool Product Destocking Hits Harder Than Expected
Pentair cut its second-quarter and full-year outlook as pool product sales face a bigger-than-expected hit from channel destocking and softe
Entain to Cut 500 Jobs as UK Online Betting Tax Hike Looms
Entain, the owner of Ladbrokes, is cutting 500 jobs to offset about £200 million in annual costs from proposed UK online betting tax hikes a
James Hardie's Beat-and-Raise Case Hinges on AZEK Synergies and Cash Flow
Oppenheimer analysts argue James Hardie can beat earnings estimates even without a housing rebound, thanks to market share gains and AZEK co
MDA Space's CLS Deal Could Transform It Into a Full-Service Space Player, RBC Says
MDA Space is in talks to buy Collecte Localisation Satellites, a move RBC says could turn it into a full-service space player with a Europea
RBC Sees Albertsons Clearing Q1 Hurdle, But Q2 Profit Squeeze Looms
RBC expects Albertsons to post a decent fiscal Q1 with adjusted EBITDA near $1.11 billion, above Wall Street estimates, even as identical sa
RBC Sees J&J Drug Pipeline Driving Growth Through 2027, MedTech Rebound Ahead
RBC Capital Markets sees Johnson & Johnson's drug business growing into 2027, with 14% ex-Stelara sales growth in Q2. The bank also expects
Cintas Posts Strong Quarter; Bank of America Sees Further Profit Growth Ahead
Cintas delivered a strong fiscal fourth quarter, with revenue rising to $2.91 billion and adjusted earnings per share up 18%. Bank of Americ
Wedbush Expects Softer Q2 for IMAX Before Stronger Second Half
Wedbush predicts IMAX will report a softer second quarter as China ticket sales and a family-heavy US movie slate limit demand. The firm exp